Man Group’s HealthEquity HQY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.1M | Sell |
67,560
-355,722
| -84% | -$30.2M | 0.01% | 1032 |
|
|
2026
Q1 | $35.4M | Buy |
423,282
+146,838
| +53% | +$12M | 0.06% | 311 |
|
|
2025
Q4 | $25.3M | Sell |
276,444
-30,837
| -10% | -$2.95M | 0.04% | 419 |
|
|
2025
Q3 | $29.1M | Buy |
307,281
+52,629
| +21% | +$4.95M | 0.05% | 394 |
|
|
2025
Q2 | $26.7M | Buy |
254,652
+236,867
| +1,332% | +$22.5M | 0.05% | 401 |
|
|
2025
Q1 | $1.57M | Sell |
17,785
-199,997
| -92% | -$20.5M | ﹤0.01% | 1451 |
|
|
2024
Q4 | $20.9M | Buy |
217,782
+5,685
| +3% | +$530K | 0.06% | 412 |
|
|
2024
Q3 | $17.4M | Buy |
212,097
+172,950
| +442% | +$13.3M | 0.05% | 501 |
|
|
2024
Q2 | $3.37M | Sell |
39,147
-207,400
| -84% | -$16.8M | 0.01% | 1169 |
|
|
2024
Q1 | $20.1M | Sell |
246,547
-172,439
| -41% | -$13.5M | 0.05% | 425 |
|
|
2023
Q4 | $27.8M | Buy |
+418,986
| New | +$29M | 0.08% | 298 |
|
|
2023
Q3 | – | Sell |
-46,957
| Closed | -$3.17M | – | 998 |
|
|
2023
Q2 | $2.96M | Buy |
+46,957
| New | +$2.72M | 0.01% | 1065 |
|
|
2022
Q4 | – | Sell |
-36,960
| Closed | -$2.48M | – | 2074 |
|
|
2022
Q3 | $2.48M | Buy |
+36,960
| New | +$2.34M | 0.01% | 992 |
|
|
2022
Q2 | – | Sell |
-126,657
| Closed | -$8.11M | – | 858 |
|
|
2022
Q1 | $8.54M | Sell |
126,657
-40,751
| -24% | -$2.2M | 0.03% | 668 |
|
|
2021
Q4 | $7.41M | Buy |
167,408
+21,422
| +15% | +$1.25M | 0.02% | 718 |
|
|
2021
Q3 | $9.45M | Buy |
145,986
+44,818
| +44% | +$3.11M | 0.03% | 586 |
|
|
2021
Q2 | $8.14M | Buy |
101,168
+56,692
| +127% | +$4.32M | 0.03% | 679 |
|
|
2021
Q1 | $3.02M | Buy |
44,476
+20,584
| +86% | +$1.62M | 0.01% | 941 |
|
|
2020
Q4 | $1.67M | Sell |
23,892
-13,357
| -36% | -$831K | 0.01% | 1261 |
|
|
2020
Q3 | $1.91M | Buy |
+37,249
| New | +$2.05M | 0.01% | 1208 |
|
|
2019
Q4 | – | Sell |
-14,385
| Closed | -$822K | – | 1866 |
|
|
2019
Q3 | $822K | Sell |
14,385
-110,581
| -88% | -$7.34M | ﹤0.01% | 1482 |
|
|
2019
Q2 | $8.17M | Buy |
124,966
+48,252
| +63% | +$3.36M | 0.03% | 724 |
|
|
2019
Q1 | $5.67M | Buy |
76,714
+56,553
| +281% | +$3.98M | 0.02% | 849 |
|
|
2018
Q4 | $1.2M | Sell |
20,161
-72,552
| -78% | -$5.85M | 0.01% | 1398 |
|
|
2018
Q3 | $8.75M | Buy |
92,713
+35,415
| +62% | +$3.05M | 0.03% | 699 |
|
|
2018
Q2 | $4.3M | Buy |
57,298
+38,087
| +198% | +$2.74M | 0.02% | 1021 |
|
|
2018
Q1 | $1.16M | Buy |
+19,211
| New | +$1.04M | 0.01% | 1469 |
|
Other funds holding HQY
WA
Man Group's HQY Position: Q2 2026 in Review
Man Group reduced its HealthEquity (HQY) stake by 84% in Q2 2026, selling an estimated $30.2M and leaving 67,560 shares worth $6.1M. The position accounts for 0.01% of the portfolio, ranked #1032.
Man Group first reported a position in HQY in Q1 2018 and has held it in 27 quarters since. The position peaked at $35.4M in Q1 2026. 498 funds tracked by Wall St. Rank hold HQY as of Q2 2026.
- Man Group held 67,560 shares of HealthEquity worth $6.1M as of Q2 2026.
- Man Group sold 355,722 HealthEquity shares in Q2 2026, an estimated $30.2M.
- HealthEquity made up 0.01% of Man Group's portfolio in Q2 2026, its #1032 holding.
- Man Group first reported a position in HealthEquity in Q1 2018 and has held it in 27 quarters since.
- Man Group's HealthEquity position peaked at $35.4M in Q1 2026.
- 498 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.